Chief Executive Officer
Daniel Bouthillier has over 25 years of experience in research administration. Mr. Bouthillier occupied various positions at Merck&Co where he was Executive Director of Research Administration and Planning for various research sites in North America. He was also Executive Director for Merck Global Facilities Management with responsibilities for Canada, US and foreign sites. In previous positions, Mr. Bouthillier was Senior Scientist and Administrator at the Clinical Research Institute of Montreal and also Head of Biochemistry at l’Hôtel-Dieu de Sorel and at Fleury Hospital in Montreal. He sits on many evaluation committees and boards such as Genome Quebec, Kaneq Bioscience and Kanyr Pharma.
Mr. Bouthillier received his Ph.D. in Clinical Sciences from the Université de Montréal and holds a certification in Clinical Biochemistry. He also completed an MBA at l’École des Hautes Études Commerciales in Montreal.